A proteomic analysis of bromobenzene reactive metabolite targets in rat liver cytosol in vivo

Chemical Research in Toxicology

Volumn 20, Issue 3, 2007, Pages 511-519

  Koen, Yakov M ^a   Gogichaeva, Natalia V ^a   Alterman, Michail A ^a,b   Hanzlik, Robert P ^a  

^a UNIVERSITY OF KANSAS   (United States)

^b CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZENE; BROMOBENZENE; BUTYLCRESOL; CARBON 14; HALOTHANE; NAPHTHALENE; PARACETAMOL; PROTOXIN; THIOBENZAMIDE;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; GEL ELECTROPHORESIS; LIVER CYTOSOL; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; METABOLIC ACTIVATION; METABOLITE; MICROSOME; NONHUMAN; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN TARGETING; PROTEOMICS; RADIOACTIVITY; RAT;

ANIMALS; BROMINE; BROMOBENZENES; CYTOSOL; DATABASES, PROTEIN; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HYDROLYSIS; LIVER; MALE; PROTEOMICS; RATS; RATS, SPRAGUE-DAWLEY; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SUBCELLULAR FRACTIONS; TRYPSIN;

RATTUS;

EID: 33947671231     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx6003166     Document Type: Article

References (59)

1. Baillie, T. A. (2006) Future of toxicology - Metabolic activation and drug design: Challenges and opportunities in chemical toxicology. Chem. Res. Toxicol. 19, 889-893.
2. Evans, D. C., Watt, A. P., Nicoll-Griffith, D. A., and Baillie, T. A. (2004) Drug - protein covalent adducts: An industry perspective on minimizing the potential for drug bioactivation in drug discovery and development. Chem. Res. Toxicol. 17, 3-16.
3. Park, K. B., Ketteringham, N. R., Maggs, J. L., Pirmohamed, M., and Williams, D. P. (2005) The role of metabolic activation in drug-induced hepatotoxicity. Annu. Rev. Pharmacol. Toxicol. 45, 177-202.
4. Ju, C., and Pohl, L. R. (2005) Tolerogenic role of Kupffer cells in immune-mediated adverse drug reactions. Toxicology 209, 109-112.
5. Kaplowitz, N. (2004) Drug-induced liver injury. Clin. Infect. Dis. 38 (Suppl. 2), S44-S48.
6. Lee, W. M. (1995) Drug-induced hepatotoxicity. New. Engl. J. Med. 333, 1118-1127.
7. Brodie, B. B., Reid, W. D., Cho, A. K., Sipes, G., Krishna, G., and Gillette, J. R. (1971) Possible mechanism of liver necrosis caused by aromatic organic compounds. Proc. Natl. Acad. Sci. U.S.A. 68, 160-164.
8. Mitchell, J. R., Jollow, D. J., Potter, W. Z., Davis, D. C., Gillette, J. R., and Brodie, B. B. (1973) Acetaminophen-induced hepatic nectosis. I. Role of drug metabolism. J. Pharmacol. Exp. Ther. 187, 185-194.
9. Jollow, D. J., Mitchell, J. R., Potter, W. Z., Davis, D. C., Gillette, J. R., and Brodie, B. B. (1973) Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo. J. Pharmacol. Exp. Ther. 187, 195-202.
10. Potter, W. Z., Davis, D. C., Mitchell, J. R., Jollow, D. J., Gillette, J. R., and Brodie, B. B. (1973) Acetaminophen-induced hepatic necrosis. III. Cytochrome P-450-mediated covalent binding in vitro. J. Pharmacol. Exp. Ther. 187, 203-210.
11. Mitchell, J. R., Jollow, D. J., Potter, W. Z., Gillette, J. R., and Brodie, B. B. (1973) Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. J. Pharmacol. Exp. Ther. 187, 211-217.
12. Deng, X., Stachlewitz, R. F., Liguori, M. J., Blomme, E. A. G., Waring, J. F., Luyendyk, J. P., Maddox, J. F., Ganey, P. E., and Roth, R. A. (2006) Modest inflammation enhances diclofenac hepatotoxicity in rats: Role of neutrophils and bacterial translocation. J. Pharmacol. Exp. Ther. 319, 1191-1199.
13. Jaeschke, H. (2005) Role of inflammation in the mechanism of acetaminophen-induced hepatotoxicity. Exp. Opin. Drug Metab. 1, 389-397.
14. Ju, C., Reilly, T. P., Bourdi, M., Radonovich, M. F., Brady, J. N., George, J. W., and Pohl, L. R. (2002) Protective role of Kupffer cells in acetaminophen-induced hepatic injury in mice. Chem. Res. Toxicol. 15, 1504-1513.
15. Tukov, F. F., Maddox, J. F., Amacher, D. E., Bobrowski, W. F., Roth, R. A., and Ganey, P. E. (2006) Modeling inflammation-drug interactions in vitro: A rat Kupffer cell-hepatocyte coculture system. Toxicol. In Vitro 20, 1488-1499.
16. Dankovic, D. A., and Billings, R. E. (1985) The role of 4-bromophenol and 4-bromocatechol in bromobenzene covalent binding and toxicity in isolated rat hepatocytes. Toxicol. Appl. Pharmacol. 79, 323-331.
17. Gottschall, D. W., Wiley, R. A., and Hanzlik, R. P. (1983) Toxicity of ortho-substituted bromobenzenes to isolated hepatocytes: Comparison to in vivo results. Toxicol. Appl. Pharmacol. 69, 55-65.
18. Thor, H., Moldeus, P., Hermanson, R., Hogberg, J., Reed, D. J., and Orrenius, S. (1978) Metabolic activation and hepatotoxicity - toxicity of bromobenzene in hepatocytes isolated from phenobarbital- and diethylmaleate-treated rats. Arch. Biochem. Biophys. 188, 122-129.
19. Thor, H., and Orrenius, S. (1980) The mechanism of bromobenzene-induced cytotoxicity studied with isolated hepatocytes. Arch. Toxicol. 44, 31-43.
20. Liebler, D. C., and Guengerich, F. P. (2005) Elucidating mechanisms of drug-induced toxicity. Nat. Rev. Drug Discovery 4, 410-420.
21. Orrenius, S., and Zhivotovsky, B. (2006) The future of toxicology - Does it matter how cells die? Chem. Res. Toxicol. 19, 729-733.
22. Kalgutkar, A. S., Gardner, I., Obach, R. S., Shaffer, C. L., Callegari, E., Henne, K. R., Mutlib, A. E., Dalvie, D. K., Lee, J. S., Nakai, Y., O'Connell, J. P., Boer, J., and Harriman, S. P. (2005) A comprehensive listing of bioactivation pathways of organic functional groups. Curr. Drug Metab. 6, 161-225.
23. Docks, E. L., and Krishna, G. (1965) Covalent binding of trans-stilbene to rat liver microsomes. Biochem. Pharmacol. 24, 1965-1969.
24. Monks, T. J., Hinson, J. A., and Gillette, J. R. (1983) Bromobenzene and p-bromophenol toxicity and covalent binding in vivo. Life Sci. 30, 841-848.
25. Roberts, S. A., and Jollow, D. J. (1978) Acetaminophen structure-toxicity relationships: Why is 3-hydroxyacetanilide not hepatotoxic? Pharmacologist 20, 259.
26. Bambal, R. B., and Hanzlik, R. P. (1995) Bromobenzene-3,4-oxide alkylates histidine and lysine side chains of rat liver proteins in vivo. Chem. Res. Toxicol. 8, 729-735.
27. Slaughter, D. E., Zheng, J., Harriman, S., and Hanzlik, R. P. (1993) Identification of covalent adducts to protein sulfur nucleophiles by alkaline permethylation. Anal. Biochem. 208, 288-295.
28. Weller, P. E., and Hanzlik, R. P. (1991) Isolation of S-(bromophenyl)-cysteine isomers from liver proteins of bromobenzene-treated rats. Chem. Res. Toxicol. 4, 17-20.
29. Koen, Y. M., and Hanzlik, R. P. (2002) Identification of seven proteins in the endoplasmic reticulum as targets for reactive metabolites of bromobenzene. Chem. Res. Toxicol. 15, 699-706.
30. Rombach, E. M., and Hanzlik, R. P. (1998) Identification of a rat liver microsomal esterase as a target protein for bromobenzene metabolites. Chem. Res. Toxicol. 11, 178-184.
31. Koen, Y. M., Williams, T. D., and Hanzlik, R. P. (2000) Identification of three protein targets for reactive metabolites of bromobenzene in rat liver cytosol. Chem. Res. Toxicol. 13, 1326-1335.
32. 14C]-aniline. J. Labelled Compd. Radiopharm. 25, 991-998.
33. Koen, Y. M., Yue, W., Galeva, N. A., Williams, T. D., and Hanzlik, R. P. (2006) Site-specific arylation of rat glutathione S-transferase A1 and A2 by bromobenzene metabolites in vivo. Chem. Res. Toxicol. 11, 1426-1434.
34. Qiu, Y., Burlingame, A. L., and Benet, L. Z. (1998) Identification of the hepatic protein targets of reactive metabolites of acetaminophen in vivo in mice using two-dimensional gel electrophoresis and mass spectrometry. J. Biol. Chem. 273, 17940-17953.
35. Witzmann, F. A., Fultz, C. D., Mangipudy, R. S., and Mehendale, H. M. (1996) Two-dimensional electrophoretic analysis of compartment-specific hepatic protein charge modification induced by thioacetamide exposure in rats. Fundam. Appl. Toxicol. 31, 124-132.
36. Schroeder, F., Jolly, C. A., Cho, T.-H., and Frolov, A. (1998) Fatty acid binding protein isoforms: Structure and function. Chem. Phys. Lipids 92, 1-25.
37. Bini, L., Magi, B., Marzocchi, B., Arcuri, F., Tripodi, S., Cintorino, M., Sanchez, J. C., Frutiger, S., Hughes, G., Pallini, V., Hochstrasser, D. F., and Tosi, P. (1997) Protein expression profiles in human breast ductal carcinoma and histologically normal tissue. Electrophoresis 18, 2832-2841.
38. Urade, R., Nasu, M., Moriyama, T., Wada, K., and Kito, M. (1992) Protein degradation by the phosphoinositide-specific phospholipase C-α family from rat liver endoplasmic reticulum. J. Biol. Chem. 267, 15152-15159.
39. Witzmann, F. A., Jarnot, B. M., and Clack, J. W. (1994) Charge modification in rodent hepatic Grp78/BiP following exposure to structurally diverse peroxisome proliferators. Appl. Theor. Electrophor. 4, 81-88.
40. Lutter, P., Meyer, H. E., Langer, M., Witthohn, K., Dormeyer, W., Sickmann, A., and Bluggel, M. (2001) Investigation of charge variants of rviscumin by two-dimensional gel electrophoresis and mass spectrometry. Electrophoresis 22, 2888-2897.
41. Yue, W., Koen, Y. M., Williams, T. D., and Hanzlik, R. P. (2005) Use of isotopic signatures for mass spectral detection of protein adduction by chemically reactive metabolites of bromobenzene: Studies with model proteins. Chem. Res. Toxicol. 18, 1748-1754.
42. LoPachin, R. M., and DeCaprio, A. P. (2005) Protein adduct formation as a molecular mechanism in neurotoxicity. Toxicol. Sci. 86, 214-225.
43. Meier, B. W., Gomez, J. D., Zhou, A., and Thompson, J. A. (2005) Immunochemical and proteomic analysis of covalent adducts formed by quinone methide tumor promoters in mouse lung epithelial cell lines. Chem. Res. Toxicol. 18, 1575-1585.
44. Lin, C. Y., Isbell, M. A., Morin, D., Boland, B. C., Salemi, M. R., Jewell, W. T., Weir, A. J., Fanucchi, M. V., Baker, G. L., Plopper, C. G., and Buckpitt, A. R. (2005) Characterization of a structurally intact in situ lung model and comparison of naphthalene protein adducts generated in this model vs lung microsomes. Chem. Res. Toxicol. 18, 802-813.
45. Nerland, D. E., Cai, J., Pierce, W. M., and Benz, F. W. (2001) Covalent binding of acrylonitrile to specific rat liver glutathione S-transferases in vivo. Chem. Res. Toxicol. 14, 799-806.
46. Nishiyama, Y., Mitsuda, Y., Taguchi, H., Planque, S., Hara, M., Karle, S., Hanson, C. V., Uda, T., and Paul, S. (2005) Broadly distributed nucleophilic reactivity of proteins coordinated with specific ligand binding activity. J. Mol. Recognit. 18, 295-306.
47. Vega, M. C., Walsh, S. B., Mantle, T. J., and Coll, M. (1998) The three-dimensional structure of Cys-47-modified mouse liver glutathione S-transferase P1-1. J. Biol. Chem. 273, 2844-2850.
48. Adang, A. E. P., Duindam, A. J. G., Brussee, J., Mulder, G. J., and Van Der Gen, A. (1988) Synthesis and nucleophilic reactivity of a series of glutathione analogues, modified at the γ-glutamyl moiety. Biochem. J. 255, 715-720.
49. Person, M. D., Mason, D. E., Liebler, D. C., Monks, T. J., and Lau, S. S. (2005) Alkylation of cytochrome c by (glutathion-S-yl)-1,4-benzoquinone and iodoacetamide demonstrates compound-dependent site specificity. Chem. Res. Toxicol. 18, 41-50.
50. Dennehy, M. K., Richards, K. A. M., Wernke, G. R., Shyr, Y., and Liebler, D. C. (2006) Cytosolic and nuclear protein targets of thiol-reactive electrophiles. Chem. Res. Toxicol. 19, 20-29.
51. Person, M. D., Monks, T. J., and Lau, S. S. (2003) An integrated approach to identifying chemically induced posttranslational modifications using comparative MALDI-MS and targeted HPLC-ESI-MS/ MS. Chem. Res. Toxicol. 16, 598-608.
52. Zhou, S. (2003) Separation and detection methods for covalent drug-protein adducts. J. Chromatogr. B 797, 63-90.
53. Nelson, S. D., and Pearson, P. G. (1990) Covalent and noncovalent interactions in acute lethal cell injury caused by chemicals. Annu. Rev. Pharmacol. Toxicol. 30, 169-195.
54. The Target Protein Database, a searchable, annotated compilation of protein targets for reactive metabolites of drugs and chemicals, can be found at http://tpdb.medchem.ku.edu:8080/protein_database/.
55. Monks, T. J., Lau, S. S., and Highet, R. J. (1984) Formation of nontoxic reactive metabolites of p-bromophenol: Identification of a new glutathione conjugate. Drug Metab. Dispos. 12, 432-437.
56. Holme, J. A., Hongslo, J. K., Bjorge, C., and Nelson, S. D. (1991) Comparative cytotoxic effects of acetaminophen (N-acetyl-p-aminophenol), a non-hepatotoxic regioisomer acetyl-m-aminophenol and their postulated reactive hydroquinone and quinone metabolites in monolayer cultures of mouse hepatocytes. Biochem. Pharmacol. 42, 1137-1142.
57. Myers, T. G., Dietz, E. C., Anderson, N. L., Khairallah, E. A., Cohen, S. D., and Nelson, S. D. (1995) A comparative study of mouse liver proteins arylated by reactive metabolites of acetaminophen and its nonhepatotoxic regioisomer, 3′-hydroxyacetanilide. Chem. Res. Toxicol. 8, 403-413.
58. Matthews, A. M., Hinson, J. A., Roberts, D. W., and Pumford, N. R. (1997) Comparison of covalent binding or acetaminophen and the regioisomer 3′-hydroxyacetanilide to mouse liver protein. Toxicol. Lett. 90, 77-82.
59. Qiu, Y., Benet, L. Z., and Burlingame, A. L. (2001) Identification of hepatic protein targets of the reactive metabolites of the non-hepatotoxic regioisomer of acetaminophen, 3′-hydroxyacetanilide, in the mouse in vivo using two-dimensional gel electrophoresis and mass spectrometry. Adv. Exp. Med. Biol. 500, 663-673.